Investing in Biotechnology Stocks (Record no. 5346)

MARC details
000 -LEADER
fixed length control field 01810nam a2200253Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field ASM
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241206153838.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241203s9999 xx 000 0 und d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2001273955
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0471479144
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780471479147
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Qualifying information Hardback
040 ## - CATALOGING SOURCE
Transcribing agency ASM
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Leo Gough
Relator term Author
110 ## - MAIN ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Leo Gough
245 #0 - TITLE STATEMENT
Title Investing in Biotechnology Stocks
Statement of responsibility, etc. Leo Gough
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Singapore
Name of publisher, distributor, etc. John Wiley & Sons
Date of publication, distribution, etc. 2001
300 ## - PHYSICAL DESCRIPTION
Extent 237 pages
Other physical details Bars
Dimensions 24 cm
520 ## - SUMMARY, ETC.
Summary, etc. "Top industry insiders tell investors what they need to know to make informed investment decisions about biotech stocks After Internet stocks, biotechs are today's most popular stock investments, and most serious investors know that biotech is one market they simply cannot afford to stay out of. But when confronted with a highly technical, rapidly evolving sector, consisting of thousands of R&D companies involved in everything from pharmaceuticals to cloning technology, many investors understandably feel unqualified to decide which stocks to pick. This book arms investors with the background knowledge and up-to-the-minute market information they need to play the biotech markets and win. Leading investment author and journalist Leo Gough provides them with a rare insider's look at the biotech industries based on extensive interviews with industry analysts, CEOs, and leading scientists at top biotech firms, including Merck & Co., Eli Lilly & Co., Amgen Ltd., SmithKline Beecham, Inc., Genzyme Corp., Monsanto, and others. Leo Gough (Singapore) edits a number of investment newsletters on emerging markets and technology stocks and is the author of thirteen investment books."
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Miscellaneous industries and trades
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type

No items available.